Results 21 to 30 of about 188,098 (289)

The anti-cancer properties of heparin and its derivatives: a review and prospect

Cell Adhesion & Migration, 2020
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma, Zhi-Xiang Mao, Yang Wu, Ming-Xing Liang, Dan-Dan Wang, Xiu Chen, Ping-an Chang, Wei Zhang, Jin-Hai Tang   +8 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source

Low molecular-weight heparin is better than warfarin for prevention of recurrent venous thromboembolism in cancer patients [PDF]

, 2017
A critical appraisal and clinical application of Lee AYY, Levin MN, Bake RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
Choi, Sarah
core   +2 more sources

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition

Gynecology Obstetrics & Reproductive Medicine, 2019
Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented.
Yasin Durmuş, Yalin Ay Karyal, Cigdem Kilic, Caner Cakir, Dilek Yuksel, Berna Seyhan, Gokhan Boyraz, Gunsu Kimyon Comert, Taner Turan   +8 more
doaj   +1 more source

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis [PDF]

, 2018
Background: Cancer-Associated thrombosis is common. Recommended treatment is daily injected low-molecular-weight heparin for 6months. Most studies focus on prophylaxis and treatment; few have explored patients’ experience.
Benelhaj, Naima B., Hutchinson, Ann, Ilyas, Muhammad Waqas, Johnson, Miriam J., Maraveyas, Anthony M., Seymour, Julie D.   +5 more
core   +1 more source

Thromboprophylaxis in obstetrics: who, when and how [PDF]

Гинекология, 2014
The article highlights the current issues of the use of anticoagulants (unfractionated and low molecular weight heparin) for the prevention of venous thromboembolic complications in obstetric practice.
A V Kulikov, E M Schiffman, I B Zabolotskikh, S V Sinkov, S R Belomestnov   +4 more
doaj  

Preventive effect of low molecular weight heparin on thrombosis formation in microvascular anastomosis

Acta Orthopaedica et Traumatologica Turcica, 2021
Antithrombotic effect of the low molecular weight heparin (L.M.W.H) in microvascular anastomosis was investigated with femoral arteries of the rats. Femoral arteries of 28 rats were cut and anastomosed end to end with microsurgical technique.
Oguz Ozdemir, Erhan Coskunol, Zeki Ozcan, Gulcin Basdemir   +3 more
doaj  

Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT

Health Technology Assessment, 2020
Background: Patients admitted to hospital for surgery are at an increased risk of venous thromboembolism. Pharmaco-thromboprophylaxis and mechanical prophylaxis (usually graduated compression stockings or intermittent pneumatic compression) have been ...
Joseph Shalhoub, Rebecca Lawton, Jemma Hudson, Christopher Baker, Andrew Bradbury, Karen Dhillon, Tamara Everington, Manjit S Gohel, Zaed Hamady, Beverly J Hunt, Gerard Stansby, David Warwick, John Norrie, Alun H Davies   +13 more
doaj   +1 more source

Heparin-Induced Hyperkalemia Assessment Utilizing the Naranjo Adverse Drug Reaction Probability Scale: A 40-Year Systematic Review

Pharmacy
Background: Adverse drug reactions have been reported as leading causes of morbidity and mortality. Unfractionated heparin- and low-molecular-weight heparin-induced hyperkalemia are side effects that have been reported in approximately 7 to 8% of heparin-
Divita Singh, Omnia A. E. A. Mesalhy, Michael J. Cawley   +2 more
doaj   +1 more source

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS

Акушерство, гинекология и репродукция, 2016
The article describes the main anticoagulant drugs used in cancer patients, taking into consideration pathogenetic aspects of hypercoagulation status in cancer patients: oral anticoagulants, heparin drugs, selective inhibitors of Xa factor.
A. V. Vorobev, A. M. Chabrov, A. A. Savchenko, A. D. Makatsariya   +3 more
doaj   +1 more source